Literature DB >> 29802120

The Protein Tyrosine Phosphatase Activity of Eyes Absent Contributes to Tumor Angiogenesis and Tumor Growth.

Yuhua Wang1, Ram Naresh Pandey1, Stephen Riffle1, Hemabindu Chintala1, Kathryn A Wikenheiser-Brokamp2, Rashmi S Hegde3.   

Abstract

DNA damage repair capacity is required for cells to survive catastrophic DNA damage and proliferate under conditions of intratumoral stress. The ability of the minor histone protein H2AX to serve as a hub for the assembly of a productive DNA damage repair complex is a necessary step in preventing DNA damage-induced cell death. The Eyes Absent (EYA) proteins dephosphorylate the terminal tyrosine residue of H2AX, thus permitting assembly of a productive DNA repair complex. Here, we use genetic and chemical biology approaches to separately query the roles of host vascular endothelial cell and tumor cell EYA in tumor growth. Deletion of Eya3 in host endothelial cells significantly reduced tumor angiogenesis and limited tumor growth in xenografts. Deletion of Eya3 in tumor cells reduced tumor cell proliferation and tumor growth without affecting tumor angiogenesis. A chemical inhibitor of the EYA tyrosine phosphatase activity inhibited both tumor angiogenesis and tumor growth. Simultaneously targeting the tumor vasculature and tumor cells is an attractive therapeutic strategy because it could counter the development of the more aggressive phenotype known to emerge from conventional antiangiogenic agents. Mol Cancer Ther; 17(8); 1659-69. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29802120      PMCID: PMC6072569          DOI: 10.1158/1535-7163.MCT-18-0057

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  53 in total

1.  Antitumor activity of targeted and cytotoxic agents in murine subcutaneous tumor models correlates with clinical response.

Authors:  Harvey Wong; Edna F Choo; Bruno Alicke; Xiao Ding; Hank La; Erin McNamara; Frank-Peter Theil; Jay Tibbitts; Lori S Friedman; Cornelis E C A Hop; Stephen E Gould
Journal:  Clin Cancer Res       Date:  2012-05-30       Impact factor: 12.531

2.  The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.

Authors:  L K Stamp; J Haslett; C Frampton; D White; D Gardner; S Stebbings; G Taylor; R Grainger; R Kumar; S Kumar; T Kain; D Porter; M Corkill; A Cathro; S Metcalfe; J Wyeth; N Dalbeth
Journal:  Intern Med J       Date:  2016-09       Impact factor: 2.048

3.  MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks.

Authors:  Manuel Stucki; Julie A Clapperton; Duaa Mohammad; Michael B Yaffe; Stephen J Smerdon; Stephen P Jackson
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

4.  Regulation of the innate immune response by threonine-phosphatase of Eyes absent.

Authors:  Yasutaka Okabe; Teruyuki Sano; Shigekazu Nagata
Journal:  Nature       Date:  2009-06-28       Impact factor: 49.962

5.  Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature.

Authors:  Jikui Shen; Maike Frye; Bonnie L Lee; Jessica L Reinardy; Joseph M McClung; Kun Ding; Masashi Kojima; Huiming Xia; Christopher Seidel; Raquel Lima e Silva; Aling Dong; Sean F Hackett; Jiangxia Wang; Brian W Howard; Dietmar Vestweber; Christopher D Kontos; Kevin G Peters; Peter A Campochiaro
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

6.  Decreased xanthine oxidoreductase (XOR) is associated with a worse prognosis in patients with serous ovarian carcinoma.

Authors:  Nina Linder; Ralf Bützow; Heini Lassus; Mikael Lundin; Johan Lundin
Journal:  Gynecol Oncol       Date:  2011-10-29       Impact factor: 5.482

7.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

Review 8.  The role of erlotinib (Tarceva, OSI 774) in the treatment of non-small cell lung cancer.

Authors:  Roman Perez-Soler
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531

9.  The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone.

Authors:  Emmanuel Tadjuidje; Tim Sen Wang; Ram Naresh Pandey; Saulius Sumanas; Richard A Lang; Rashmi S Hegde
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

10.  WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity.

Authors:  Andrew Xiao; Haitao Li; David Shechter; Sung Hee Ahn; Laura A Fabrizio; Hediye Erdjument-Bromage; Satoko Ishibe-Murakami; Bin Wang; Paul Tempst; Kay Hofmann; Dinshaw J Patel; Stephen J Elledge; C David Allis
Journal:  Nature       Date:  2008-12-17       Impact factor: 49.962

View more
  6 in total

Review 1.  The multi-functional eyes absent proteins.

Authors:  Rashmi S Hegde; Kaushik Roychoudhury; Ram Naresh Pandey
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-07-29       Impact factor: 8.250

2.  Targeting EYA3 in Ewing Sarcoma Retards Tumor Growth and Angiogenesis.

Authors:  Yuhua Wang; Ram Naresh Pandey; Kaushik Roychoudhury; David Milewski; Tanya V Kalin; Sara Szabo; Joseph G Pressey; Rashmi S Hegde
Journal:  Mol Cancer Ther       Date:  2021-03-01       Impact factor: 6.009

3.  The EYA3 tyrosine phosphatase activity promotes pulmonary vascular remodeling in pulmonary arterial hypertension.

Authors:  Yuhua Wang; Ram Naresh Pandey; Allen J York; Jaya Mallela; William C Nichols; Yueh-Chiang Hu; Jeffery D Molkentin; Kathryn A Wikenheiser-Brokamp; Rashmi S Hegde
Journal:  Nat Commun       Date:  2019-09-12       Impact factor: 14.919

4.  Analysis of EYA3 Phosphorylation by Src Kinase Identifies Residues Involved in Cell Proliferation.

Authors:  Aura E Ionescu; Mihaela Mentel; Cristian V A Munteanu; Livia E Sima; Eliza C Martin; Georgiana Necula-Petrareanu; Stefan E Szedlacsek
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

Review 5.  The Eyes Absent Proteins: Unusual HAD Family Tyrosine Phosphatases.

Authors:  Kaushik Roychoudhury; Rashmi S Hegde
Journal:  Int J Mol Sci       Date:  2021-04-10       Impact factor: 5.923

Review 6.  The Eyes Absent proteins in development and in developmental disorders.

Authors:  Upendra Kumar Soni; Kaushik Roychoudhury; Rashmi S Hegde
Journal:  Biochem Soc Trans       Date:  2021-06-30       Impact factor: 5.407

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.